XENETIC BIOSCIENCES, INC. Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)
XENETIC BIOSCIENCES, INC. (XBIO) reported Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease) of $18.28 thousand for the 3-month period ending 2013-11-30, per its 10-Q filed 2014-01-10.
Discontinued › Notes
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease · last filed 2014-01-10
- XENETIC BIOSCIENCES, INC. accumulated depreciation, depletion and amortization, property, plant and equipment, period increase (decrease) for the quarter ending 2013-11-30 was $18.28K, a 244.12% increase year-over-year.
- XENETIC BIOSCIENCES, INC. accumulated depreciation, depletion and amortization, property, plant and equipment, period increase (decrease) for the quarter ending 2012-11-30 was $5.31K.
- XENETIC BIOSCIENCES, INC. accumulated depreciation, depletion and amortization, property, plant and equipment, period increase (decrease) for fiscal 2013 was $38.55K, a 97.86% increase from fiscal 2012.
- XENETIC BIOSCIENCES, INC. accumulated depreciation, depletion and amortization, property, plant and equipment, period increase (decrease) for fiscal 2012 was $19.48K.
| Period end | Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease) 3 month | Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease) 12 month |
|---|---|---|
| 2013-11-30 | $18.28K 10-Q · filed 2014-01-10 | |
| 2013-08-31 | $38.55K 10-K · filed 2013-11-27 | |
| 2012-11-30 | $5.31K 10-Q · filed 2014-01-10 | |
| 2012-08-31 | $19.48K 10-K · filed 2013-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |